Gan & Lee Pharmaceuticals. (603087.SS) SHH

67.88

+4.27(+6.71%)

Updated at August 19 01:56PM

Currency In CNY

Valuation

Market Cap26.06B
Enterprise Value25.16B
P/E Ratio48.31
PEG Ratio1.34
Price/Sales Ratio11.64
Price/Book Ratio3.55
Enterprise/Revenue11.34
Enterprise/EBITDA36.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.24
Operating Margin0.2

Management Effectiveness

Return On Assets0.07
Return On Equity0.07

Income Statement

Revenue3.05B
Revenue/Share5.88
Gross Profit2.28B
EBITDA888.13M
Net Income614.66M
Diluted EPS1.04

Balance Sheet

Total Cash2.36B
Total Cash/Share4
Total Debt3.06M
Total Debt/Equity0
Current Ratio4.92
Book Value Per Share19.22

Price History

52-Week Change58.85
52-Week High69.97
52-Week Low37.63
Moving Average 50 Days57.95
Moving Average 200 Days49.18

Statistics

Average Volume17.78M
Shares Outstanding591.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield1.47
Payout Ratio0.51
Last Split Factor7:5
Last Split DateAugust 20, 2020